Looking back: a review of policy implications for exercise oncology.


Journal

Journal of the National Cancer Institute. Monographs
ISSN: 1745-6614
Titre abrégé: J Natl Cancer Inst Monogr
Pays: United States
ID NLM: 9011255

Informations de publication

Date de publication:
04 05 2023
Historique:
accepted: 13 01 2023
received: 11 10 2022
revised: 16 12 2022
medline: 5 5 2023
pubmed: 4 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

The evidence to support the benefits of exercise for people living with and beyond cancer is robust. Still, exercise oncology interventions in the United States are only eligible for coverage by third-party payers within the restrictions of cancer rehabilitation settings. Without expanded coverage, access will remain highly inequitable, tending toward the most well-resourced. This article describes the pathway to third-party coverage for 3 programs that address a chronic disease and utilize exercise professionals: the Diabetes Prevention Program, Supervised Exercise Training for Peripheral Artery Disease, and Cancer Rehabilitation. Lessons learned will be applied toward expanding third-party coverage for exercise oncology programming.

Identifiants

pubmed: 37139975
pii: 7150909
doi: 10.1093/jncimonographs/lgad002
pmc: PMC10501465
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-148

Subventions

Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Circulation. 2019 Jan 22;139(4):e10-e33
pubmed: 30586765
Support Care Cancer. 2022 Mar;30(3):2397-2405
pubmed: 34766199
Am J Occup Ther. 2017 Mar/Apr;71(2):7102100030p1-7102100030p11
pubmed: 28218585
Rehabil Nurs. 2018 Jul/Aug;43(4):186-194
pubmed: 29957695
J Natl Cancer Inst. 2018 Aug 1;110(8):815-824
pubmed: 29982543
J Am Coll Cardiol. 2015 Mar 17;65(10):999-1009
pubmed: 25766947
Support Care Cancer. 2009 Jan;17(1):61-7
pubmed: 18478275
Am J Prev Med. 2013 Apr;44(4 Suppl 4):S301-6
pubmed: 23498291
J Oncol Pract. 2019 Jun;15(6):e520-e528
pubmed: 31095436
Disabil Rehabil. 2020 Jan;42(1):8-13
pubmed: 30574818
J Clin Oncol. 2008 Jun 1;26(16):2621-9
pubmed: 18509174
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
J Vasc Surg. 2020 May;71(5):1702-1707
pubmed: 31699514
Cancer. 2019 Nov 15;125(22):3908-3916
pubmed: 31390063
J Clin Oncol. 2022 Aug 1;40(22):2491-2507
pubmed: 35576506
Am J Manag Care. 2013;19(3):194-202
pubmed: 23544761
Med Clin North Am. 1969 May;53(3):607-24
pubmed: 4305950
Am J Manag Care. 2018 Oct;24(10):475-478
pubmed: 30325189
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
Fed Regist. 2017 Nov 15;82(219):52976-3371
pubmed: 29231695
J Sci Med Sport. 2019 Nov;22(11):1175-1199
pubmed: 31277921
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Am J Manag Care. 2020 Jun 1;26(6):e198-e201
pubmed: 32549070
Semin Oncol Nurs. 2020 Feb;36(1):150975
pubmed: 32007288
PM R. 2017 Sep;9(9S2):S317-S323
pubmed: 28942906
PM R. 2017 Sep;9(9S2):S398-S406
pubmed: 28942911
Diabetes Metab Syndr Obes. 2020 Aug 19;13:2949-2957
pubmed: 32903871
Circulation. 2017 Mar 21;135(12):e686-e725
pubmed: 27840332
Am J Prev Med. 2019 Mar;56(3):452-457
pubmed: 30661888
J Cancer Surviv. 2022 Aug;16(4):865-881
pubmed: 34510366
Cancer. 2021 Feb 1;127(3):476-484
pubmed: 33090477
J Cancer Educ. 2018 Oct;33(5):947-953
pubmed: 28064402
CA Cancer J Clin. 2013 Sep;63(5):295-317
pubmed: 23856764
Diabetes Care. 2002 Dec;25(12):2165-71
pubmed: 12453955
JAMA Netw Open. 2021 Oct 1;4(10):e2128797
pubmed: 34623412
JAMA. 2021 Aug 24;326(8):736-743
pubmed: 34427594
Diabetes Care. 2012 Apr;35(4):723-30
pubmed: 22442395
PM R. 2017 Sep;9(9S2):S297-S304
pubmed: 28942904
Phys Ther. 2015 Dec;95(12):1680-91
pubmed: 26112257
Circulation. 2019 Sep 24;140(13):e700-e710
pubmed: 31446770
Vasc Med. 2021 Dec;26(6):654-656
pubmed: 34404282
Circ Cardiovasc Qual Outcomes. 2021 Aug;14(8):e007953
pubmed: 34293930
J Cancer Rehabil. 2018;1:1-8
pubmed: 30882090
Med Sci Sports Exerc. 2019 Nov;51(11):2391-2402
pubmed: 31626056
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
J Palliat Med. 2012 Aug;15(8):923-30
pubmed: 22731514
Circulation. 2012 Jan 3;125(1):130-9
pubmed: 22090168

Auteurs

Mary A Kennedy (MA)

Nutrition and Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.

Melanie Potiaumpai (M)

Milton S. Hershey College of Medicine, Public Health Sciences, Pennsylvania State University, Hershey, PA, USA.

Melissa Maitin-Shepard (M)

MMS Health Strategies, LLC, Alexandria, VA, USA.

Christopher M Wilson (CM)

Physical Therapy Program, School of Health Sciences, Oakland University, Rochester, MI, USA.

Anna Campbell (A)

School of Applied Sciences, Edinburgh Napier University, Edinburgh, United Kingdom.

Anna L Schwartz (AL)

College of Nursing, University of Nebraska Medical Center, Omaha, NE, USA.

Jessica Gorzelitz (J)

Department of Health and Human Physiology, University of Iowa, Iowa City, IA, USA.

Maxime Caru (M)

Milton S. Hershey College of Medicine, Public Health Sciences, Pennsylvania State University, Hershey, PA, USA.

Chloe Grimmett (C)

School of Health Sciences, University of Southampton, Southampton, United Kingdom.

Kathryn H Schmitz (KH)

Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH